U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc's
2023-05-19 05:28
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate
2023-05-13 04:55